Dr. Clauder’s, a prominent figure in the pet food industry, has forged a strategic partnership with protein innovator Calysta to unveil the world’s inaugural line of dog treats crafted with FeedKind® Pet protein, marking a significant advancement in pet nutrition.
Unveiled at Interzoo, the premier global pet trade fair, the pioneering air-dried treat by Dr. Clauder’s leverages the nutritional richness of Calysta’s innovative protein, produced through natural fermentation. This process yields a non-GMO ingredient that resonates with market preferences for superior nutritional content, palatability, and pet well-being.
Following its debut at Interzoo, the Dr. Clauder Trainee snack infused with FeedKind Pet protein will become commercially available across Europe, offering pet owners a novel dietary option.
FeedKind Pet protein stands out as a fermented ingredient renowned for its nutrient density, complete amino acid profile tailored for dogs, and postbiotic attributes conducive to maintaining optimal gut health in animals. Remarkably, this protein source is also vegan-friendly.
Herman Sloot, Vice President of Commercial Development at Calysta, emphasized the evolving expectations of pet owners regarding food quality and ingredient provenance. He underscored the significance of FeedKind Pet protein in meeting these demands, highlighting its nutritional excellence, eco-friendliness, and regulatory approval for pet food applications in the European Union. Sloot expressed enthusiasm for Dr. Clauder’s initiative in introducing a treat featuring FeedKind Pet protein, heralding a new benchmark for dog snacks that seamlessly meld taste, nutrition, and environmental stewardship.
Alexander Gerards, Managing Partner at Dr. Clauder’s solutions for pets, underscored the market resonance of eco-conscious, vegetarian, and delectable protein sources. He lauded the collaborative effort that birthed the Dr. Clauder’s Trainee Snack, extolling its vegetarian composition, comprehensive amino acid profile, and flavorful appeal as a testament to innovation aligned with consumer preferences.
Alan Shaw, Co-founder and CEO of Calysta, highlighted the burgeoning global pet population and the imperative for sustainable, nutritionally optimized pet food solutions. He hailed FeedKind Pet protein as a transformative offering benefiting pets, owners, and the environment alike. Shaw celebrated the landmark introduction of Europe’s inaugural pet food product featuring FeedKind Pet, marking a pivotal moment for Calysta and the pet nutrition landscape.
The collaboration between Dr. Clauder’s and Calysta signifies a paradigm shift in pet nutrition, underscoring a commitment to excellence, sustainability, and pet well-being on a global scale.
